Tech Company Acquirers

Sangamo BioSciences

Ceregene was purchased by Sangamo BioSciences, a leading biopharmaceutical provider%, located in Richmond.

Company Overview

Contact Information

Company Background Information

Overview

Sangamo BioSciences, Inc. (NASDAQ: SGMO) is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. The Company has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic for the treatment of HIV/AIDS.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/27/2013

Acquisitions By Sangamo BioSciences

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sandy Macrae

        

Chief Financial Officer

Kathy Yi

        

Chief Marketing Officer

Edward Conner

        

Chief Technical Officer

Edward Rebar

        

Vice President

Duncan McKay

        

VP - Bus. Development

McDavid Stilwell

        

VP - General Counsel

Heather Turner

        

VP - Manufacturing

Andrew Ramelmeier

        

VP - Product Management

Nathalie Dubois-Stringfellow

        

Browse more tech company acquirers:

Sandoz | Sanofi

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary